Contact
Please use this form to send email to PR contact of this press release:
Phase 1 CD-19 specific third generation CAR T cell study data supports use of BioOra’s automated manufacture for phase 2
TO:
Rachael Joel
Botica Butler Raudon for BioOra
+64 21 403 504